Publications by authors named "Sandra Pinkert"

Claim this Profile
A
Assessing customized multivalent chemokine-binding peptide treatment in a murine model of coxsackievirus B3 myocarditis.
Nicolas Kelm, Meike Kespohl, Gintare Smagurauskaite, Serena Vales, Kalimuthu Karuppanan, Sandra Pinkert

Basic Res Cardiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TF-FVIIa PAR2-β-Arrestin Signaling Sustains Organ Dysfunction in Coxsackievirus B3 Infection of Mice.
Meike Kespohl, Carl Christoph Goetzke, Nadine Althof, Clara Bredow, Nicolas Kelm, Sandra Pinkert

Arterioscler Thromb Vasc Biol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Conserved Cysteine Residue in Coxsackievirus B3 Protein 3A with Implication for Elevated Virulence.
Martin Voss, Sandra Pinkert, Meike Kespohl, Niclas Gimber, Karin Klingel

Viruses· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of Analgesia with Tramadol in the Coxsackievirus B3 Myocarditis Mouse Model.
Sandra Pinkert, Meike Kespohl, Nicolas Kelm, Ziya Kaya, Arnd Heuser

Viruses· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression.
Janik Böhnke, Sandra Pinkert, Maria Schmidt, Hans Binder, Nicole Christin Bilz

Int J Mol Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Point Mutations within the Coxsackie B Virus Receptor-Binding Site Promote Resistance against Soluble Virus Receptor Traps.
Sandra Pinkert, Anja Kopp, Vanessa Brückner, Henry Fechner, Antje Beling

J Virol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
Sandra Pinkert, Markian Pryshliak, Kathleen Pappritz, Klaus Knoch, Ahmet Hazini

Cardiovasc Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-375-mediated suppression of engineered coxsackievirus B3 in pancreatic cells.
Markian Pryshliak, Ahmet Hazini, Klaus Knoch, Babette Dieringer, Beatrice Tolksdorf, Sandra Pinkert

FEBS Lett· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Sandra Pinkert, Babette Dieringer, Robert Klopfleisch, Konstantinos Savvatis, Sophie Van Linthout

Circ Heart Fail· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma.
Ahmet Hazini, Markian Pryshliak, Vanessa Brückner, Karin Klingel, Martina Sauter, Sandra Pinkert

Hum Gene Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis.
Madlen Loebel, Luise Holzhauser, Jelka A Hartwig, Praphulla C Shukla, Konstantinos Savvatis, Sandra Pinkert

Eur Heart J· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological antivirals for treatment of adenovirus infections.
Katrin Schaar, Carsten Röger, Tanja Pozzuto, Jens Kurreck, Sandra Pinkert

Antivir Ther· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunoproteasome-specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis.
Nadine Althof, Carl Christoph Goetzke, Meike Kespohl, Karolin Voss, Arnd Heuser, Sandra Pinkert

EMBO Mol Med· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection of iPSC Lines with Miscarriage-Associated Coxsackievirus and Measles Virus and Teratogenic Rubella Virus as a Model for Viral Impairment of Early Human Embryogenesis.
Denise Hübner, Kristin Jahn, Sandra Pinkert, Janik Böhnke, Matthias Jung

ACS Infect Dis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Carsten Tschöpe, Irene Müller, Yu Xia, Konstantinos Savvatis, Kathleen Pappritz, Sandra Pinkert

Circ Heart Fail· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters.
Katrin Schaar, Anja Geisler, Milena Kraus, Sandra Pinkert, Markian Pryshliak

Mol Ther Nucleic Acids· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus.
Sandra Pinkert, Babette Dieringer, Sabine Diedrich, Heinz Zeichhardt, Jens Kurreck

Antiviral Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Coxsackievirus and Adenovirus Receptor: Glycosylation and the Extracellular D2 Domain Are Not Required for Coxsackievirus B3 Infection.
Sandra Pinkert, Carsten Röger, Jens Kurreck, Jeffrey M Bergelson, Henry Fechner

J Virol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel artificial microRNA expressing AAV vector for phospholamban silencing in cardiomyocytes improves Ca2+ uptake into the sarcoplasmic reticulum.
Tobias Gröβl, Elke Hammer, Sandra Bien-Möller, Anja Geisler, Sandra Pinkert

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
Elisabeth A Stein, Sandra Pinkert, Peter Moritz Becher, Anja Geisler, Heinz Zeichhardt

J Infect Dis· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of the multimeric nuclear egress complex of human cytomegalovirus.
Jens Milbradt, Alexandra Kraut, Corina Hutterer, Eric Sonntag, Cathrin Schmeiser, Sandra Pinkert

Mol Cell Proteomics· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interspecies differences in virus uptake versus cardiac function of the coxsackievirus and adenovirus receptor.
Fabian Freiberg, Martina Sauter, Sandra Pinkert, Thirupugal Govindarajan, Joanna Kaldrack

J Virol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of mutated miR-206 target sites enables skeletal muscle-specific silencing of transgene expression of cardiotropic AAV9 vectors.
Anja Geisler, Christian Schön, Tobias Größl, Sandra Pinkert, Elisabeth A Stein

Mol Ther· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line.
Sandra Pinkert, Karin Klingel, Vanessa Lindig, Andrea Dörner, Heinz Zeichhardt

J Virol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections.
Henry Fechner, Sandra Pinkert, Anja Geisler, Wolfgang Poller, Jens Kurreck

Molecules· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis